Feng (Johnson) Qian, MD, PhD, MBA, MS

Associate Professor of Health Policy and Management
Dept. of HPMB, School of Public Health, University at Albany – SUNY, Rensselaer, NY, USA

Associate Professor Feng (Johnson) Qian is a health services researcher whose work focuses on quality of care and outcomes research, evaluation of healthcare innovations and digital health. He is passionate about enabling Big Data, artificial intelligence, and medical innovations to disrupt healthcare industry and improve population health and happiness. He has published over 40 papers in peer-reviewed journals and is a regular reviewer for leading medical journals and national/international conferences. His research involves assessing the effects of different generations and different types of coronary stents in treating coronary artery disease (Co-PI for a R01 grant funded by AHRQ), the impact of adding laboratory values to the cardiac registries in predicting risk-adjusted outcomes (site Co-PI for a R01 grant funded by AHRQ), as well as examining the clinical profile, process of care, short-term and long-term outcomes in understudied Asian-Americans (PI for multiple studies funded by American Heart Association). He served as the national Program Director of Asian & Pacific Islander Caucus for Public Health and now serves as a member of the New York State Cardiovascular Advisory Committee Executive Committee and as the Chair of the Faculty Council at the School of Public Health, University at Albany – State University of New York.

He has led cross-institutional cross-functional teams to conduct innovative research that investigates the feasibility and value of using real-world Big Data for population-based hypertension surveillance and cancer screening management. He also examined patient navigation program’s cost and benefit for colorectal cancer screening in underserved Chinese American communities. He teaches graduate level courses related to economic analysis for health policy and management, economic evaluation in healthcare industry, public health leadership and strategy, healthcare analytics and data mining, cardiovascular outcomes research, and global health.

He obtained his PhD in health services research and policy from the University of Rochester. His MSc in Clinical Science was from the National University of Singapore and his medical education and residency training in cardiac surgery was from Shanghai Medical University (now Shanghai Medical College of Fudan University), China. He received his MBA degree from Columbia Business School.

Terms of Appointment: September 2019 - August 2021